R.W. Blarney

514 total citations
24 papers, 377 citations indexed

About

R.W. Blarney is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, R.W. Blarney has authored 24 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 12 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in R.W. Blarney's work include Breast Cancer Treatment Studies (14 papers), Breast Lesions and Carcinomas (7 papers) and Estrogen and related hormone effects (6 papers). R.W. Blarney is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), Breast Lesions and Carcinomas (7 papers) and Estrogen and related hormone effects (6 papers). R.W. Blarney collaborates with scholars based in United Kingdom and Netherlands. R.W. Blarney's co-authors include J.F.R. Robertson, C.W. Elston, Ian O. Ellis, Peter C. Willsher, F.S. Kenny, A P Locker, Roger J. Ordidge, L. Jackson, P. Mansfield and Stephen Chan and has published in prestigious journals such as British journal of surgery, European Journal of Cancer and Breast Cancer Research and Treatment.

In The Last Decade

R.W. Blarney

24 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R.W. Blarney United Kingdom	12	252	209	128	119	75	24	377
TJ Anderson United Kingdom	7	220 0.9×	408 2.0×	106 0.8×	147 1.2×	48 0.6×	8	548
C I Li United States	6	333 1.3×	306 1.5×	192 1.5×	122 1.0×	78 1.0×	7	666
K Hisamatsu Japan	12	168 0.7×	229 1.1×	59 0.5×	66 0.6×	74 1.0×	35	361
Lars Löfgren Sweden	10	181 0.7×	106 0.5×	99 0.8×	70 0.6×	42 0.6×	22	369
Farid Jamshidian United States	11	292 1.2×	185 0.9×	107 0.8×	90 0.8×	79 1.1×	27	397
J.H.C.L. Hendriks Netherlands	9	239 0.9×	378 1.8×	215 1.7×	146 1.2×	94 1.3×	21	639
Stephen DeSantis United States	12	300 1.2×	211 1.0×	205 1.6×	62 0.5×	69 0.9×	14	478
W Mattheiem Belgium	12	312 1.2×	283 1.4×	135 1.1×	261 2.2×	49 0.7×	33	647
M.J. Mitchell United Kingdom	4	263 1.0×	205 1.0×	127 1.0×	49 0.4×	42 0.6×	4	334
J Lamb United Kingdom	10	260 1.0×	256 1.2×	278 2.2×	41 0.3×	32 0.4×	11	465

Countries citing papers authored by R.W. Blarney

Since Specialization

Citations

This map shows the geographic impact of R.W. Blarney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.W. Blarney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.W. Blarney more than expected).

Fields of papers citing papers by R.W. Blarney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.W. Blarney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.W. Blarney. The network helps show where R.W. Blarney may publish in the future.

Co-authorship network of co-authors of R.W. Blarney

This figure shows the co-authorship network connecting the top 25 collaborators of R.W. Blarney. A scholar is included among the top collaborators of R.W. Blarney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.W. Blarney. R.W. Blarney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Duffy, Sandra & R.W. Blarney. (2008). Long-term mortality results from the UK Breast Screening Frequency Trial. European Journal of Cancer Supplements. 6(7). 48–48. 5 indexed citations

Blarney, R.W., U Chetty, T Bates, et al.. (2008). Radiotherapy and/or Tamoxifen after conserving surgery for breast cancers of excellent prognosis: BASO II trial. European Journal of Cancer Supplements. 6(7). 55–55. 7 indexed citations

Kaufmann, M., W. Jonat, R.W. Blarney, et al.. (2002). Updated survival results from the Zebra trial.. Breast Cancer Research and Treatment. 76. 2 indexed citations

Teh, William, H.C. Burrell, Andrew Evans, et al.. (1998). Ultrasound guided core biopsy of suspicious mammographic calcifications using high frequency and power Doppler ultrasound. European Journal of Cancer. 34. S70–S71. 3 indexed citations

Klijn, J.G.M., R.W. Blarney, Francesco Boccardo, et al.. (1998). A new standard treatment for advanced premenopausal breast cancer: A meta-analysis of the Combined Hormonal Agent Trialists Group (CHAT). European Journal of Cancer. 34. S90–S90. 11 indexed citations

Robertson, J.F.R., Anthony Howell, Daniel J. Friend, R.W. Blarney, & P. Walton. (1997). Duration of remission to ICI 182,780 compared to megestrol acetate in tamoxifen resistant breast cancer. The Breast. 6(4). 186–189. 26 indexed citations

Willsher, Peter C., John F. R. Robertson, Stephen Chan, L. Jackson, & R.W. Blarney. (1997). Locally advanced breast cancer: early results of a randomised trial of multimodal therapy versus initial hormone therapy. European Journal of Cancer. 33(1). 45–49. 26 indexed citations

Kollias, James, et al.. (1997). 0-24. Loss of heterozygosity in premenopausal bilateral breast cancer. The Breast. 6(4). 231–231. 1 indexed citations

Sibbering, D.M., S Pinder, Ian O. Ellis, et al.. (1997). 0-20. Local excision with a 10 mm margin as sole treatment for ductal carcinoma in situ (DCIS) of the breast. The Breast. 6(4). 230–230. 1 indexed citations

10.

Pinder, S, C.W. Elston, Joshua A. Bell, et al.. (1997). Intratumoural heterogeneity of proliferation in invasive breast carcinoma evaluated with MIBI antibody. The Breast. 6(4). 171–176. 22 indexed citations

11.

Robertson, J.F.R., Stefan Krämer, C. Selby, et al.. (1997). 0-35. Guiding systemic therapy in metastatic breast cancer by blood tumour markers. The Breast. 6(4). 234–234. 1 indexed citations

12.

Day, N E, et al.. (1997). 0-107/0-108. The UKCCCR breast screening frequency trial: results on predicted mortality. The Breast. 6(4). 254–255. 1 indexed citations

13.

Kenny, F.S., Peter C. Willsher, Julia M.W. Gee, et al.. (1997). 0-10. Change in expression of ER and bcl-2 predict for quality and duration of response in endocrine sensitive breast cancer. The Breast. 6(4). 227–227. 1 indexed citations

14.

Beckingham, Ian J., et al.. (1994). The use of DNA typing to clarify the origin of metastatic carcinoma after renal transplantation:A clinical and medico-legal problem. Transplant International. 7(5). 379–381. 1 indexed citations

15.

Dixon, AR, Joshua A. Bell, Ian O. Ellis, et al.. (1992). Tumour oestrogen receptor content allows selection of elderly patients with breast cancer for conservative tamoxifen treatment. British journal of surgery. 79(12). 1314–1316. 20 indexed citations

16.

Ellis, Ian O., et al.. (1990). The relationship of “high risk” mammographic patterns to histological risk factors for development of cancer in the human breast. British Journal of Radiology. 63(755). 845–849. 24 indexed citations

17.

Locker, A P, et al.. (1990). Evaluation of the prognostic value of triple node biopsy in early breast cancer. British journal of surgery. 77(2). 163–167. 25 indexed citations

18.

Robertson, J.F.R., R.I. Nicholson, K.J. Walker, & R.W. Blarney. (1989). Zoladex in Advanced Breast Cancer. Hormone Research. 32(1). 206–208. 5 indexed citations

19.

Robertson, J.F.R., Michael R. Williams, J H Todd, & R.W. Blarney. (1989). Mitoxantrone—A Useful Palliative Therapy in Advanced Breast Cancer. American Journal of Clinical Oncology. 12(5). 393–396. 9 indexed citations

20.

Mansfield, P., Peter G. Morris, Roger J. Ordidge, et al.. (1979). Carcinoma of the breast imaged by nuclear magnetic resonance (NMR). British Journal of Radiology. 52(615). 242–243. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact